Alzheimer's disease (AD) is the most common neurodegenerative disease among the
elderly with a progressive decline in cognitive function significantly affecting quality of life …

Aging is associated with alterations in cognitive processing and brain neurophysiology.
Whereas the primary symptom of amnestic mild cognitive impairment (aMCI) is memory …

There has been an increasing trend towards the use of complexity analysis in quantifying
neural activity measured by electroencephalography (EEG) signals. On top of revealing …

Healthy aging is associated with impairment in cognitive information processing. Several
neuroimaging methods such as functional magnetic resonance imaging, positron emission …

Alzheimer's disease (AD) is a degenerative brain disease with a high and irreversible
incidence. In recent years, because brain signals have complex nonlinear dynamics, there …

Electroencephalography (EEG) has long been studied as a potential diagnostic method for
Alzheimer's disease (AD). The pathological progression of AD leads to cortical …

Alzheimer's Disease (AD) is considered one of the most diseases that much prevalent
among elderly people all over the world. AD is an incurable neurodegenerative disease …

Alzheimer's disease (AD) is a progressive disorder that affects cognitive brain functions and
starts many years before its clinical manifestations. A biomarker that provides a quantitative …

Current biomarkers used in research and in clinical practice in Alzheimer's Disease (AD) are
the analysis of cerebral spinal fluid (CSF) to detect levels of Aβ42 and phosphorylated-tau …

Neuropathic pain in people with spinal cord injury is thought to be due to altered central
neuronal activity. A novel therapeutic intervention using virtual reality (VR) head-mounted …